Ossiam Has $4.68 Million Holdings in Church & Dwight Co., Inc. (NYSE:CHD)

Ossiam trimmed its holdings in Church & Dwight Co., Inc. (NYSE:CHD) by 12.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 44,684 shares of the company’s stock after selling 6,506 shares during the period. Ossiam’s holdings in Church & Dwight were worth $4,679,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in CHD. Barclays PLC raised its position in shares of Church & Dwight by 63.9% in the third quarter. Barclays PLC now owns 1,106,131 shares of the company’s stock valued at $115,832,000 after purchasing an additional 431,257 shares during the period. World Investment Advisors LLC acquired a new stake in Church & Dwight during the third quarter worth approximately $58,338,000. Wilmington Savings Fund Society FSB boosted its holdings in shares of Church & Dwight by 25.7% during the third quarter. Wilmington Savings Fund Society FSB now owns 76,404 shares of the company’s stock worth $8,001,000 after acquiring an additional 15,598 shares during the period. Tidal Investments LLC grew its position in shares of Church & Dwight by 5.2% in the third quarter. Tidal Investments LLC now owns 18,000 shares of the company’s stock valued at $1,885,000 after purchasing an additional 896 shares during the last quarter. Finally, Synovus Financial Corp increased its stake in shares of Church & Dwight by 6.7% during the third quarter. Synovus Financial Corp now owns 19,556 shares of the company’s stock worth $2,048,000 after purchasing an additional 1,221 shares during the period. 86.60% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CHD has been the topic of a number of research reports. Truist Financial upped their price objective on Church & Dwight from $110.00 to $115.00 and gave the company a “buy” rating in a report on Monday, February 3rd. Wells Fargo & Company boosted their price objective on shares of Church & Dwight from $115.00 to $120.00 and gave the company an “overweight” rating in a report on Wednesday, April 2nd. Bank of America raised shares of Church & Dwight from a “neutral” rating to a “buy” rating and raised their target price for the stock from $112.00 to $125.00 in a report on Tuesday, April 15th. UBS Group increased their price target on Church & Dwight from $109.00 to $110.00 and gave the stock a “neutral” rating in a research report on Thursday. Finally, JPMorgan Chase & Co. cut their target price on Church & Dwight from $106.00 to $98.00 and set an “underweight” rating for the company in a research report on Friday, April 11th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $112.59.

Church & Dwight Price Performance

Church & Dwight stock opened at $105.32 on Friday. The stock has a 50-day moving average price of $107.23 and a two-hundred day moving average price of $106.10. Church & Dwight Co., Inc. has a 12 month low of $96.35 and a 12 month high of $116.46. The company has a current ratio of 1.70, a quick ratio of 1.24 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $25.92 billion, a PE ratio of 44.44, a P/E/G ratio of 3.32 and a beta of 0.55.

Church & Dwight (NYSE:CHD) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.77 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.77. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. During the same period in the previous year, the company posted $0.65 earnings per share. Analysts expect that Church & Dwight Co., Inc. will post 3.7 EPS for the current year.

Church & Dwight Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 3rd. Stockholders of record on Friday, February 14th were paid a $0.295 dividend. This is a boost from Church & Dwight’s previous quarterly dividend of $0.28. The ex-dividend date was Friday, February 14th. This represents a $1.18 annualized dividend and a dividend yield of 1.12%. Church & Dwight’s dividend payout ratio is presently 49.79%.

Insider Transactions at Church & Dwight

In related news, EVP Rene Hemsey sold 11,060 shares of the business’s stock in a transaction on Wednesday, March 12th. The shares were sold at an average price of $109.98, for a total value of $1,216,378.80. Following the transaction, the executive vice president now owns 6,437 shares in the company, valued at $707,941.26. The trade was a 63.21 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Maynadier Patrick D. De sold 54,510 shares of the company’s stock in a transaction on Monday, March 10th. The shares were sold at an average price of $115.98, for a total transaction of $6,322,069.80. Following the sale, the executive vice president now directly owns 10,497 shares in the company, valued at $1,217,442.06. This trade represents a 83.85 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 65,570 shares of company stock worth $7,538,449 over the last ninety days. 1.20% of the stock is owned by insiders.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.